Banque Cantonale Vaudoise Schrodinger, Inc. Transaction History

Banque Cantonale Vaudoise

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$16.24 - $26.38 $7,307 - $11,871	-450 Reduced 13.04%	3,000 $56,000
Q3 2022 Oct 17, 2022	SELL	$23.95 - $34.71 $16,765 - $24,297	-700 Reduced 16.87%	3,450 $86,000
Q2 2022 Aug 02, 2022	BUY	$21.39 - $35.9 $25,668 - $43,080	1,200 Added 40.68%	4,150 $109,000
Q3 2021 Oct 29, 2021	SELL	$53.75 - $76.55 $173,720 - $247,409	-3,232 Reduced 52.28%	2,950 $161,000
Q2 2021 Aug 11, 2021	BUY	$59.02 - $78.8 $83,690 - $111,738	1,418 Added 29.76%	6,182 $468,000
Q1 2021 May 11, 2021	BUY	$64.61 - $113.09 $262,575 - $459,597	4,064 Added 580.57%	4,764 $363,000
Q4 2020 Feb 05, 2021	SELL	$48.06 - $84.4 $63,102 - $110,817	-1,313 Reduced 65.23%	700 $55,000
Q3 2020 Oct 30, 2020	SELL	$46.87 - $93.33 $216,633 - $431,371	-4,622 Reduced 69.66%	2,013 $95,000
Q2 2020 Jul 22, 2020	BUY	$36.12 - $91.57 $41,646 - $105,580	1,153 Added 21.03%	6,635 $608,000
Q1 2020 May 14, 2020	BUY	$26.6 - $52.99 $145,821 - $290,491	5,482 New	5,482 $236,000

235

60.7M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.22B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.